Mylan announces new VP global business development

PITTSBURGH Generic drug maker Mylan announced Tuesday that it made an appointment to its executive leadership team.

Mylan appointed former Merrill Lynch investment banker Andrew Cuneo as VP global business development. The company said Cuneo is responsible for coordinating its global business development and strategic efforts.

“Drew brings a wealth of experience in the pharmaceutical, biotechnology and healthcare sectors,” Mylan vice chairman and CEO Robert Coury said in a statement. “His familiarity with our industry – and in particular with Mylan, given his and Merrill Lynch’s active role with the company during the past five years – makes him ideally suited to support the company’s continued growth.”

Most recently, Cuneo served as Merrill Lynch’s director in its global healthcare investment banking group. He earned his bachelor’s degree in economics and psychology from Vanderbilt University.